Drug Repurposing and Off-Label Use

Impact of Trump's Promotion of Unproven COVID-19 Treatments and Subsequent Internet Trends: Observational Study

Kacper Niburski, Oskar Niburski

J Med Internet Res 2020 (Nov 23); 22(11):e20044

Download Citation: END BibTex RIS

Toward Preparing a Knowledge Base to Explore Potential Drugs and Biomedical Entities Related to COVID-19: Automated Computational Approach

Junaed Younus Khan, Md Tawkat Islam Khondaker, Iram Tazim Hoque, Hamada R H Al-Absi, Mohammad Saifur Rahman, Reto Guler, Tanvir Alam, M Sohel Rahman

JMIR Med Inform 2020 (Nov 10); 8(11):e21648

Download Citation: END BibTex RIS

No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19

Moshe Rogosnitzky, Esther Berkowitz, Alejandro R Jadad

JMIRx Med 2020 (Sep 30); 1(1):e19583

Download Citation: END BibTex RIS

Artificial Intelligence for Rapid Meta-Analysis: Case Study on Ocular Toxicity of Hydroxychloroquine

Matthew Michelson, Tiffany Chow, Neil A Martin, Mike Ross, Amelia Tee Qiao Ying, Steven Minton

J Med Internet Res 2020 (Aug 17); 22(8):e20007

Download Citation: END BibTex RIS

Understanding Drug Repurposing From the Perspective of Biomedical Entities and Their Evolution: Bibliographic Research Using Aspirin

Xin Li, Justin F. Rousseau, Ying Ding, Min Song, Wei Lu

JMIR Med Inform 2020 (Jun 16); 8(6):e16739

Download Citation: END BibTex RIS

Delivering Benefits at Speed Through Real-World Repurposing of Off-Patent Drugs: The COVID-19 Pandemic as a Case in Point

Moshe Rogosnitzky, Esther Berkowitz, Alejandro R Jadad

JMIR Public Health Surveill 2020 (May 13); 6(2):e19199

Download Citation: END BibTex RIS